[ O U R M I S S I O N ]
EuSenseMedical delivers products that are certain to bring the best Quality of Life
based on our continuous research and development.
In our rapidly aging society, we see more people suffering from dysphagia and aspiration pneumonia.
We aim to contribute to a better future of social welfare in Japan
through translational research that develops from diagnosis, prevention to treatment.
Swallowing Monitoring System
Dysphagia Treatment System
Emotion Recognition App
[ M E S S A G E F R O M T H E F O U N D E R / C E O ]
Nurturing Lives in Japan's Aging Society through Clinical Experiences
EuSense Medical is committed to delivering products designed to significantly improve the Quality of Life, a commitment rooted in our ongoing research and development endeavors. In our rapidly aging society, the prevalence of dysphagia and aspiration pneumonia is increasing, highlighting the urgent need for solutions. Our goal is to contribute to a brighter future for social welfare in Japan by conducting translational research that spans from diagnosis and prevention to treatment.
Reflecting on my past, I worked on Awaji Island in the Osaka Bay area. In 2004, during a home visit, I encountered a patient grappling with dyspnea (breathlessness) and dysphagia (swallowing disorder) resulting from a brainstem stroke (Wallenburg syndrome). Witnessing this struggle became a serendipitous moment that fueled my determination to develop a device facilitating swallowing, drawing upon my background as a respiratory physiologist.
Several years later, another serendipitous encounter occurred when I crossed paths with Hiroshi Ueno, CEO of JCraft. Together, we created an interferential current-type low-frequency electrical stimulator. In 2013, EuSense Medical Co., Ltd. was established with a clear vision to transform basic medical research into innovative products that authentically enhance people's well-being. Our steadfast mission and passion are centered around safeguarding the physical and mental health of individuals. Guided by this principle, EuSense Medical advances confidently, one step at a time.
EuSense Medical.Ltd. CEO
Dr. Yoshitaka Oku (MD., PhD.)
About our CEO, Dr.Oku
Founder and CEO of EuSense Medical Ltd. (2013 - present) / Director of Oku Clinic in Awaji Island, Hyogo, Japan (reopened 2023 - present) / Professor at Department of Physiology, Hyogo College of Medical University, Japan (2005 - 2023) / Director of Oku Clinic (2000 - 2005) / Instructor, Department of Medical Systems Control, Institute for Frontier Medical Sciences, Kyoto University, Japan (1998 - 1999) / Humbolt Foundation Research Fellow, Department of Neurophysiology, Gottingen University, Germany (1997) / Instructor, Department of Clinical Physiology, Chest Disease Research Institute, Kyoto University, Japan (1993-1996) / Research Associate, Department of Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Japan (1992) / Research Associate, Pulmonary Division, Department of Medicine, Case Western Reserve University, USA (1989 - 1991) / PhD trainee, Chest Disease Research Institute, Kyoto University, Japan (1986-1988), Resident as a chest surgeon, Chest Disease Research
Institute, Kyoto University, Japan (1983-1985)
Certification and Professional Association
Councilor and Research Ethics Committee Member of the Physiological Society of Japan
Certified Respiratory Physician (the Japanese Respiratory Society)
Swallowing Consultant Doctor (the Society of Swallowing and Dysphagia of Japan)
Certified Physician (the Japanese Society of Internal Medicine)
Occupational Physician certified by Japan Medical Association
[ Updates on New Releases, Exhibitions, and Lectures ]
2024.2.11 [ Lecture ]
Our CEO, Dr.Oku will be presenting at "The 47th Annual Meeting of the Society of Swallowing and Dysphagia of Japan" on February 10th, 2024.